Activation of estrogen receptors with E2 downregulates peroxisome proliferator-activated receptor γ in hepatocellular carcinoma

Yueh Min Lin, Bharath Kumar Velmurugan, Yu Lan Yeh, Chuan Chou Tu, Tsung Jung Ho, Tung-Iuan Lai, Chih Hao Tsai, Fuu Jen Tsai, Chang Hai Tsai, Chih Yang Huang

研究成果: 雜誌貢獻文章同行評審

18 引文 斯高帕斯(Scopus)

摘要

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality and occurs more often in men than in women; however, little is known about its underlying molecular mechanisms. The present study investigated the effect of estrogen receptor (ER)α and ERβ on peroxisome proliferator-activated receptor γ (PPARγ) expression in Hep3B cells. We examined PPARγ, ERα and ERβ mRNA and protein expression by RT-PCR and western blotting. In order to determine whether PPARγ plays a central role in HCC, we screened for PPARγ expression in liver cancer patient tissues and differentially differentiated HCC cell lines (HA22T, Huh-7, Hep3B and HepG2). We found that PPARγ expression was highly expressed in liver cancer tissues and in Hep3B cells. Furthermore, overexpression of ERα and ERβ was found to decrease PPARγ expression at the transcriptional as well as at the translational level in a ligand-dependent manner. In summary, the present study demonstrated that both ERα and β were sufficient to inhibit PPARγ and provide a valuable therapeutic option for the treatment of HCC patients.
原文英語
頁(從 - 到)3027-3031
頁數5
期刊Oncology Reports
30
發行號6
DOIs
出版狀態已發佈 - 十二月 2013

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

指紋 深入研究「Activation of estrogen receptors with E2 downregulates peroxisome proliferator-activated receptor γ in hepatocellular carcinoma」主題。共同形成了獨特的指紋。

引用此